
High-dose semaglutide drives greater weight loss. Safety remains favorable but needs further study. A weekly semaglutide dose of 7.2 mg has been shown to markedly enhance weight loss and improve health outcomes for adults with obesity, including those who also have type 2 diabetes (T2D). Evidence from two large, international phase 3 clinical trials, published [...]